Medicine and Psychedelics

As mental health continues to decline, what will happen when medicine and virtual worlds come together in the Metaverse? The world is becoming more connected as cryptocurrency, blockchain, nonfungible token projects, the Metaverse and other online communities gain popularity.

However, we’re also seeing rates of depression and feelings of isolation and loneliness skyrocket. This development is certainly not causal, but it is something to consider as younger generations become more involved in virtual spaces. The global COVID-19 pandemic has exacerbated a national mental health crisis. Mental Health America reported that 47.1 million people in the U.S. are living with a mental health condition..

Would you consider logging onto your computer to meet with your cryptographically certified doctor or therapist? How about receiving a prescription delivered to your door? Many young people actually feel more comfortable in a virtual setting, surrounded by peers and represented by their chosen avatar.

So how does this dream become reality? It all starts with innovation and nature. Researchers and doctors have been exploring the medicinal world of fungi and their power to heal and regenerate. Fungi have been core to this planet’s wellbeing for billions of years, and we’re just beginning to understand the psychoactive effects that certain fungi have on the human psyche.

President Richard Nixon put a halt to all research on psychedelics in 1970 when he deemed renowned psychologist and writer Timothy Leary the most dangerous man in America. He began the war on drugs and convinced society that these psychoactively medicinal fungi were the devil’s work. Scientific research into the benefits of psychedelics was set back twenty years before researchers could start back up and resume their studies. Now, psychedelics are making headlines, and the efficacy of the treatments is showing possibly the best results known to science.

Through psychedelic therapies, such as those being professionally performed in research being conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), the UC Berkeley Center for the Science of Psychedelics, the Center for Psychedelic Medicine in NYU Langone’s Department of Psychiatry, the Center for Psychedelic Research at Imperial College London, the Johns Hopkins Center for Psychedelic and Consciousness Research, and other institutions, patients are learning how to process their trauma instead of suppressing it. With minimal doses of psychedelic medicine, recovery rates trend upwards and patients continue to get better on their own.

Source: https://cointelegraph.com

 

Comments are closed.